Welcome to Wallops Island, Virginia. This episode takes you behind the construction of Rocket Lab’s Launch Complex-3 where it's preparing for Neutron rocket to take flight. On the Atlantic ...

Just as some catch the golf bug after a heroic shot on the course, Dr. Kwon caught his in a lab. "The golf swing has so many mechanical components," he says. "Once I started studying it ...

Gordon covers the Healthcare sector, focusing on stocks such as Galapagos, Argenx Se, and Takeda Pharmaceutical Company. Currently, the analyst consensus on GlaxoSmithKline is a Hold with an ...

As the pharmaceutical company embarks on its largest manufacturing bid across the pond, GSK has strengthened supply chains closer to home this year. The company outlaid nearly $260m for its UK sites ...

US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...

GSK (LSE: GSK) has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. The UK pharma major said that up to $800 million investment will bring ...

GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring state-of-the-art drug substance manufacturing and additional ...

Bearish flow noted in GSK (GSK) Pharma with 3,674 puts trading, or 5x expected. Most active are 10/25 weekly 38 puts and Nov-24 40 calls, with total volume in those strikes near 3,100 contracts.

(Continued from "Pharma news highlights: court cases, controversy and increased transparency efforts") Unarguably, the most sensational item over the past few weeks has been the GlaxoSmithKline ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.